These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3475040)
1. [Factors controlling the differentiation and cancerization of murine erythroleukemia cells]. Obinata M Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):1989-95. PubMed ID: 3475040 [TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system. Tsiftsoglou AS; Wong W Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045 [TBL] [Abstract][Full Text] [Related]
3. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole. Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412 [TBL] [Abstract][Full Text] [Related]
4. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related]
6. Inhibition by dexamethasone of commitment to erythroid differentiation in murine erythroleukemia cells. Tsiftsoglou AS; Gusella JF; Volloch V; Housman DE Cancer Res; 1979 Oct; 39(10):3849-55. PubMed ID: 289436 [TBL] [Abstract][Full Text] [Related]
7. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia. Marks PA; Murate T; Kaneda T; Ravetch J; Rifkind RA Symp Fundam Cancer Res; 1984; 37():327-40. PubMed ID: 6084863 [TBL] [Abstract][Full Text] [Related]
8. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression. Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594 [TBL] [Abstract][Full Text] [Related]
10. Regulated expression of human globin genes and flanking DNA in mouse erythroleukemia--human cell hybrids. Zavodny PJ; Roginski RS; Skoultchi AI Prog Clin Biol Res; 1983; 134():53-62. PubMed ID: 6582523 [TBL] [Abstract][Full Text] [Related]
11. mNotch1 signaling and erythropoietin cooperate in erythroid differentiation of multipotent progenitor cells and upregulate beta-globin. Henning K; Schroeder T; Schwanbeck R; Rieber N; Bresnick EH; Just U Exp Hematol; 2007 Sep; 35(9):1321-32. PubMed ID: 17637499 [TBL] [Abstract][Full Text] [Related]
12. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A; Arai K Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012 [TBL] [Abstract][Full Text] [Related]
13. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells. Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728 [TBL] [Abstract][Full Text] [Related]
14. [Differentiation and malignant suppression induced by mouse erythroid differentiation and denucleation factor on mouse erythroleukemia cells]. Zhao Q; Ge YH; Zhou JP; Ma J; Chen KQ; Xue SP; Han DS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):32-5. PubMed ID: 12905814 [TBL] [Abstract][Full Text] [Related]
16. Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells. Watanabe T; Shafman T; Kufe DW J Cell Physiol; 1985 Mar; 122(3):435-40. PubMed ID: 3918047 [TBL] [Abstract][Full Text] [Related]
17. Modulation of gene expression during terminal cell differentiation. Marks PA; Sheffery M; Rifkind RA Prog Clin Biol Res; 1985; 191():185-203. PubMed ID: 3901038 [TBL] [Abstract][Full Text] [Related]
18. Idiotype mimicry by a differentiation antigen on Friend erythroleukemia cells. Ardman B; DiMambro E; Levy SB; Schwartz RS J Immunol; 1987 Sep; 139(6):2038-43. PubMed ID: 3476672 [TBL] [Abstract][Full Text] [Related]
19. Significance of the cell cycle in commitment of murine erythroleukemia cells to erythroid differentiation. Geller R; Levenson R; Housman D J Cell Physiol; 1978 May; 95(2):213-22. PubMed ID: 274446 [TBL] [Abstract][Full Text] [Related]
20. Perturbation of growth and differentiation of Friend murine erythroleukemia cells by 5-bromodeoxyuridine incorporation in early S phase. Brown EH; Schildkraut CL J Cell Physiol; 1979 May; 99(2):261-78. PubMed ID: 287673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]